These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 24016509

  • 21. Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke.
    Binici Z, Intzilakis T, Nielsen OW, Køber L, Sajadieh A.
    Circulation; 2010 May 04; 121(17):1904-11. PubMed ID: 20404258
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
    Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, Puu M, Yusuf S, Pfeffer MA, CHARM Investigators.
    J Am Coll Cardiol; 2006 May 16; 47(10):1997-2004. PubMed ID: 16697316
    [Abstract] [Full Text] [Related]

  • 24. Patients with atrial fibrillation and an alternative primary diagnosis in the emergency department: a description of their characteristics and outcomes.
    Atzema CL, Lam K, Young C, Kester-Greene N.
    Acad Emerg Med; 2013 Feb 16; 20(2):193-9. PubMed ID: 23406079
    [Abstract] [Full Text] [Related]

  • 25. Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: incidence and risk factors.
    Walkey AJ, Greiner MA, Heckbert SR, Jensen PN, Piccini JP, Sinner MF, Curtis LH, Benjamin EJ.
    Am Heart J; 2013 Jun 16; 165(6):949-955.e3. PubMed ID: 23708166
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation.
    Nakagawa K, Hirai T, Takashima S, Fukuda N, Ohara K, Sasahara E, Taguchi Y, Dougu N, Nozawa T, Tanaka K, Inoue H.
    Am J Cardiol; 2011 Mar 15; 107(6):912-6. PubMed ID: 21247518
    [Abstract] [Full Text] [Related]

  • 30. Transient atrial fibrillation and risk of stroke after acute myocardial infarction.
    Bishara R, Telman G, Bahouth F, Lessick J, Aronson D.
    Thromb Haemost; 2011 Nov 15; 106(5):877-84. PubMed ID: 21866303
    [Abstract] [Full Text] [Related]

  • 31. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States.
    Kim MH, Johnston SS, Chu BC, Dalal MR, Schulman KL.
    Circ Cardiovasc Qual Outcomes; 2011 May 15; 4(3):313-20. PubMed ID: 21540439
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation: A Competing-Risk Analysis of a Nationwide Cohort.
    Shih CJ, Ou SM, Chao PW, Kuo SC, Lee YJ, Yang CY, Tarng DC, Lin CC, Huang PH, Li SY, Chen YT.
    Circulation; 2016 Jan 19; 133(3):265-72. PubMed ID: 26680239
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L, Blanchette CM, Qian J, Yang HW, Zhao L, Zuckerman IH, Pak GH, Silver H, Dalal AA.
    Am J Geriatr Pharmacother; 2009 Oct 19; 7(5):262-70. PubMed ID: 19948302
    [Abstract] [Full Text] [Related]

  • 37. Associations between atrial fibrillation and early outcomes of patients with heart failure and reduced or preserved ejection fraction.
    Eapen ZJ, Greiner MA, Fonarow GC, Yuan Z, Mills RM, Hernandez AF, Curtis LH.
    Am Heart J; 2014 Mar 19; 167(3):369-375.e2. PubMed ID: 24576522
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    O'Meara E, Khairy P, Blanchet MC, de Denus S, Pedersen OD, Levesque S, Talajic M, Ducharme A, White M, Racine N, Rouleau JL, Tardif JC, Roy D, AF-CHF investigators.
    Circ Heart Fail; 2012 Sep 01; 5(5):586-93. PubMed ID: 22798522
    [Abstract] [Full Text] [Related]

  • 40. Peripheral arterial disease and atrial fibrillation and risk of stroke, heart failure hospitalization and cardiovascular death: A nationwide cohort study.
    Lin YS, Tung TH, Wang J, Chen YF, Chen TH, Lin MS, Chi CC, Chen MC.
    Int J Cardiol; 2016 Jan 15; 203():204-11. PubMed ID: 26512838
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.